Dong-A Socio Holdings Co., Ltd. logo

Dong-A Socio Holdings Co., Ltd. (000640)

Market Closed
19 Dec, 06:30
KRX SM KRX SM
110,300. 00
+5,400
+5.15%
718.83B Market Cap
- P/E Ratio
1,400% Div Yield
13,194 Volume
10,433 Eps
104.9K
Previous Close
Day Range
102,300 110,300
Year Range
93,600 128,500
Want to track 000640 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000640 Chart

Dong-A Socio Holdings Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Jae-Hun Jung CEO
KRX SM Exchange
KR7000640003 ISIN
KR Country
- Employees
- Last Dividend
8 Apr 2013 Last Split
- IPO Date

Overview

Dong-A Socio Holdings Co., Ltd., headquartered in Seoul, South Korea, is a prominent entity in the global pharmaceutical industry with a rich heritage dating back to its founding in 1932. The company's operations span across various sectors, including pharmaceuticals, healthcare solutions, and consumer goods, as well as engaging in Information Technology (IT) and construction services. With a global footprint, Dong-A Socio Holdings is committed to improving the quality of life through its innovative products and services. The company's dedication to research and development in the pharmaceutical field is evident in its extensive product pipeline, focused on addressing a range of health issues from chronic diseases to acute medical conditions.

Products and Services

  • Pharmaceuticals:

    Dong-A Socio Holdings is at the forefront of developing groundbreaking medications, including:

    • DA-1241 for type 2 diabetes and non-alcoholic steatohepatitis.
    • DA-1726, an oxyntomodulin analogue aimed at treating obesity.
    • DA-1229, a dipeptidyl peptidase-4 inhibitor for type 2 diabetes management.
    • DA-8010, a muscarinic M3 receptor antagonist for overactive bladder treatment.
    • DMB-3115, a biosimilar of Stelara for inflammatory diseases.
    • DA-3880 for anemia treatment.
    • STP0404, an innovative HIV-1 treatment drug.
    • STP1002, an anti-cancer drug under development.
  • Healthcare Solutions:

    The company offers a range of healthcare products and services including over-the-counter medication, consumer healthcare products, derma business solutions, and more aimed at enhancing customer wellness.

  • CDMO Services:

    Providing comprehensive Contract Development and Manufacturing Organization services, Dong-A Socio Holdings caters to the needs of the pharmaceutical industry, offering expert solutions in drug development and manufacturing.

  • Medical Products:

    The company manufactures and supplies imaging equipment and ENT workstation products, catering to various medical needs and improving patient care quality.

  • Consumer Goods:

    Dong-A Socio Holdings produces and distributes mineral water under the brand name Cheonnyeonsu, alongside a diverse range of consumer-oriented products including glass bottles, PET, and corrugated cardboard boxes.

  • IT and Construction Services:

    Expanding beyond pharmaceuticals and healthcare, the company also offers services in IT and construction, contributing to infrastructure development and technological advancement.

  • Additional Ventures:

    Engaging in the foundry equipment, logistics, and food and beverage industries, Dong-A Socio Holdings diversifies its operations, aiming to address a broad spectrum of consumer and industry needs.

Contact Information

Address: 64, Cheonho-daero, Seoul, South Korea, 02587
Phone: 82 2 920 8114